ArticleJournal of neuroinflammation2026
An irradiation-free platform for localized skull bone marrow manipulation to dissect the skull-brain axis.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The skull bone marrow (SBM) has recently emerged as a crucial regulator of brain physiology and pathology. However, its direct impact on the brain remains elusive, as existing methods cannot isolate local SBM functions from systemic confounds. Here, we developed an irradiation-free cranial bone flap transplantation platform that enables localized SBM replacement and niche-preserving engraftment. Our method establishes exclusive chimerism within CNS compartments, achieving a "peripherally clean" profile that cleanly separates SBM-brain communication from systemic variables. Comprehensive characterization of this model revealed age- and sex-dependent chimerism patterns specifically within central nervous system (CNS) niches. In contrast to conventional long bone marrow (LBM) transplantation, our model achieved robust CNS-targeted engraftment with minimal peripheral involvement. Proof-of-concept functional studies further demonstrated its functional utility by attenuating brain aging and neuroinflammation through young SBM transplantation into old recipients. Our model provides a targeted approach to dissect the skull-brain axis in health and disease, opening avenues to decipher its role in neurological disorders and to identify niche-specific therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.